Gemcitabine Prevents TCC Relapse
CHICAGO—Intravesical gemcitabine is an effective and well tolerated adjuvant local chemotherapy in patients with superficial bladder cancer, according to researchers in Algeria.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.